share_log

JP Morgan Maintains Neutral on Atea Pharmaceuticals, Lowers Price Target to $8

Benzinga ·  Mar 16, 2023 08:51

JP Morgan analyst Eric Joseph maintains Atea Pharmaceuticals (NASDAQ:AVIR) with a Neutral and lowers the price target from $12 to $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment